MedTrace Logo

Mass Drug Administrations of DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique

NCT02914145 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240502

Last updated 2018-02-06

No results posted yet for this study

Summary

In line with the global and regional efforts towards malaria elimination, a five year program was established to assist the NMCP in adopting targeted evidence-based elimination plans through a 'learn by doing' strategy. The project aims to generate knowledge as data is generated to inform the programmatic aspects of the elimination plan, most importantly how to clear malaria parasites from the asymptomatic reservoir.

Conditions

Interventions

DRUG

Dihydroartemisinin-piperaquine

Mass drug administration

Sponsors & Collaborators

  • Barcelona Institute for Global Health

    collaborator OTHER

  • Centro de Investigacao em Saude de Manhica

    lead OTHER

Principal Investigators

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2017-12-31
Completion
2017-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02914145 on ClinicalTrials.gov